1401601

Source:http://linkedlifedata.com/resource/pubmed/id/1401601

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0027051, umls-concept:C0155626, umls-concept:C0205390, umls-concept:C0449243, umls-concept:C0520997, umls-concept:C1257890, umls-concept:C1444748, umls-concept:C1514623, umls-concept:C1516451, umls-concept:C2603343
pubmed:issue	5
pubmed:dateCreated	1992-11-25
pubmed:abstractText	The aim of this study was to provide insight into the mechanism of acute myocardial infarction by determining the modifiers of timing and possible triggers of onset of infarction.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset	AIM
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0735-1097
pubmed:author	pubmed-author:BraunwaldEE, pubmed-author:FormanSS, pubmed-author:KnatterudG LGL, pubmed-author:MullenJ AJA, pubmed-author:SolomonR ERE, pubmed-author:StoneP HPH, pubmed-author:ToflerG HGH
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	20
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1049-55
pubmed:dateRevised	2010-3-24
pubmed:meshHeading	pubmed-meshheading:1401601-Analysis of Variance, pubmed-meshheading:1401601-Circadian Rhythm, pubmed-meshheading:1401601-Humans, pubmed-meshheading:1401601-Myocardial Infarction, pubmed-meshheading:1401601-Physical Exertion, pubmed-meshheading:1401601-Prognosis, pubmed-meshheading:1401601-Regression Analysis, pubmed-meshheading:1401601-Thrombolytic Therapy, pubmed-meshheading:1401601-Time Factors
pubmed:year	1992
pubmed:articleTitle	Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group.
pubmed:affiliation	Division of Cardiology, New England Deaconess Hospital, Boston, Massachusetts.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Clinical Trial, Phase II